




Genten Therapeutics, Inc. - Biotechnology- Johnson  FormDs.com - SEC filings of fundraisings and investments in hedge funds, private equity firms, startups, and growing companies 











 FormDs.com 





 Newest
 Filter
 Local




 









Genten Therapeutics, Inc.

      Industry: Biotechnology
      (See others in industry)

Address:



    600 Montgomery Street Suite 1700 
    San Francisco, CA, 94111Phone: 4158353900 




Filings



Date
FilingType
Reported Sold
Incremental Cash 
Type
Exemptions
Link to Raw Filing




	2016-10-03


New


$12,000,000


$12,000,000


Equity Only


06b


SEC link






Directors and Executives (Current and Past)



Name
Role



 Craig Johnson 
 Director, Executive 


 David Mauney 
 Director, Executive 





















 




Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Genten Therapeutics, Inc. - Who is raising money? | SEC filings of fundraisings and investments in hedge funds, startups and private equity companies















Who is raising money?











Genten Therapeutics, Inc.  Funding details


Genten Therapeutics, Inc. Industry: BiotechnologyCIK Number: 0001685989IRS Number: 813858436Address: 600 MONTGOMERY STREET  SAN FRANCISCO 94111Phone number: 4158353900



Latest news
Genten Therapeutics, Inc. raised $12,000,000 from 3 investors on 2016-10-03.



Genten Therapeutics, Inc. Filings

DateFiling TypeOfferedSoldRemainingMin. investmentInvest. countExemption / Exlusions
2016-10-03New Form D$22,000,000$12,000,000$10,000,000$0306b[SEC Filing]
Genten Therapeutics, Inc. raised $12,000,000 in total.



Directors and Executives of Genten Therapeutics, Inc.
Key People in Genten Therapeutics, Inc.:

David MauneyCraig Johnson








Last visited companies: Murvin & Meier Oil Co, NAVIGATOR INVESTORS L P, NEXT BIG SOUND INC, Oregon Film Group, LLC, PAAMCO AK Absolute Return Fund Ltd Partnership

								© whoisraisingmoney.com
Daily updated news about investment into startups, hedge funds and private equity companies.
















Genten Therapeutics, Inc. - List of CEOs, founders and company directors

















directorpedia.net - List of CEOs, founders, board members and company directors











Genten Therapeutics, Inc.
List of persons related to the company Genten Therapeutics, Inc.. Find out list of CEOs, founders, board members, and company directors of Genten Therapeutics, Inc..

CIK Number: 0001685989IRS Number: 813858436Company address: 600 MONTGOMERY STREET  SAN FRANCISCO 94111Phone number: 4158353900



People related to Genten Therapeutics, Inc.
NamePositionStreetCityCountryR. Johnson  Craig600 Montgomery Street Suite 1700San FranciscoCAMauney  David600 Montgomery Street Suite 1700San FranciscoCA




Genten Therapeutics, Inc. on the Web












 








	ActoBiotic for celiac disease - Product Profile - BioCentury





























































Publications
archives
BCIQ
Conferences
version 4.3.15.600





Free Trial / Subscribe


SIGN IN



English
简体中文
日本語
한국어







Biocentury





Menu





                                        Home
                                        
+




                                        Publications
                                        
+



Publications Home >


BioCentury>


BC Innovations>


BC Extra>


BC Week In Review>


Current Issues>




Archives 
                                        
+



Archives Home >


Basic Search>


Advanced Search>


Back Issues>




BCIQ
                                        
+



BCIQ Home >


Overview>


Pipeline Analyst>


Financial Analyst>


Company Analyst>


Deal Analyst>




Conferences 
                                        
+




Conferences Home >


Newsmakers


Bio€quity Europe


Future Leaders


China Healthcare Summit


Other Industry Events





eLearning 
                                        
+



eLearning Home >


Videos>


White Papers>


                                            Follow Us
                                            


























BCIQ / Product Profile


BCIQ Overview   |    
                        Settings   |   
                        Support















Biocentury



Print this                                                    
                        














                                

    

    

    
 
                            


                                ActoBiotic for celiac disease
                            









print preview


bookmark


share with colleague
























General Information
                                







Company
Intrexon Corp.


DescriptionActoBiotic delivering immunogenic antigens of gluten

Molecular Target




Mechanism of Action 

Therapeutic ModalityBiologic: Protein






Latest Stage of DevelopmentPreclinical

Standard IndicationCeliac disease

Indication DetailsTreat celiac disease

Regulatory Designation


PartnerGenten Therapeutics Inc.





 Product Summary: Number of Indications in each Phase of Development by Disease Category

More 






 Product Details
                                        


















 Archive Items are loading
                                            













Deals Information
                                    






 Deals Summary




Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1000




 Deals Details
                                            




DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/23/2016Intrexon  (Licensor)Genten  (Licensee)Intrexon grants Genten Therapeutics exclusive access to its ActoBiotics platform to deliver therapies against celiac diseaseUndisclosed0Undisclosed































About Biocentury


Company Overview


Management


Editorial & Research




Contact


Contact Us


Advertising & Sponsorship


Career Opportunities




Support


Forgot Password


Customer Service


Reprints


FAQs




Products & Solutions


Products Overview


Publications


Archives


BCIQ


Conferences


eLearning


RSS Feeds




Legal


User Agreement


Terms of Use


Privacy Policy


Your California Privacy Rights


Use of Images

Follow Us
                            











What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.

Sign in
Free Trial












© 2017 BioCentury Inc. All Rights Reserved.
     
                        Terms & Conditions
                          |  
                        Privacy Policy










Set Email Alert






dummy












Genten Therapeutics, Inc.: Private Company Information - Bloomberg









































  





















































































July 28, 2017 7:32 PM ET
Biotechnology

Company Overview of Genten Therapeutics, Inc.



Snapshot People




Company Overview
Genten Therapeutics, Inc. develops a monotherapy through an antigen specific induction of immune tolerance for gluten. The company was incorporated in 2016 and is based in San Francisco, California.


600 Montgomery StreetSuite 1700San Francisco, CA 94111United StatesFounded in 2016



Phone: 415-835-3900








Key Executives for Genten Therapeutics, Inc.




Mr. David Mauney


      	Executive Director
      








Mr. Craig Johnson


      	Executive Director
      





Compensation as of Fiscal Year 2017. 



Similar Private Companies By Industry



Company Name
Region



 20n Labs, Inc. United States 23andMe, Inc. United States 2C Tech Corporation, Inc. United States 3-V Biosciences, Inc. United States 3Bar Biologics Inc. United States




Recent Private Companies Transactions



TypeDate
Target





Private Placement

			      September 22, 2016
			    
--





Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Genten Therapeutics, Inc., please visit --.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





























 SECGems:

Form D 
	
		Genten Therapeutics, Inc.
	

	

   


	0001685989-16-000001 








































  







			Data feeds now available
			Excel / CSV / Java / Python /etc 
Database
Learn more









  




  


  
































 
						Genten Therapeutics, Inc. 
					

					D
				

					  0001685989-16-000001 
				


				Notice of exempt offering of securities - made without registration ( Regulation D and Section 4 Small Businesses ) 










 
							filing date 
						


Oct. 3, 2016

 
							effectiveness date 
						


Oct. 3, 2016

 
							date of filing date change 
						


Oct. 3, 2016



Signed By

 Edward Y. Kim


						accession number
					
 
						
						  0001685989-16-000001
						
					

						type
					
 
						
						  D
						
					

						public document count
					
 
						
						  1
						
					

							items descs
						

								06b Federal Exemptions and Exclusions: Rule 506(b)
							





New!



		Contact
	


Looking to load all Form D filings easily into a spreadsheet or database?

Subscribe to files containing this and  over 250,000++ Form D filings from 2008 - Now
Easily sort / filter/graph offerings based on 'Offering Amount', 'city/state', 'Industry','# investors', and every field seen in this filing


Load in Microsoft Excel / Google Sheets 
Developers: CSV files work with Python / Java / databases, etc
API access Get access to all filings - old and new via real-time API
Real-Time alerts for this and all other form types






Key documents and exhibits


Link:
Type
Id
filename




 
					
 	  					D
 	  				
				


D


1


 primary_doc.xml







 






	  Primary Issuer 
	


Genten Therapeutics, Inc.


			[ Corporation ] 
			 Jurisdiction: 
			DELAWARE
		


	 
	
	 600 MONTGOMERY STREET
	 
	  Suite 1700
	
	   SAN FRANCISCO, 
	   CA, 
	  
	
	  
		
		

			
			 
		
		
		
		 USA
		
	
	   4158353900    
	    

		
	

	  Related Persons
	


David Mauney

[ Executive Officer ] 
[ Director ] 

	 
	
	 600 Montgomery Street
	 
	 ,  Suite 1700
	
	  ,  San Francisco, 
	   CA, 
	  
	
	  
		
		, 
		
	    
	    
		    
			  
			
			 
		
		
		
		 USA
		
	
	    
	    

		
	


Craig Johnson

[ Executive Officer ] 
[ Director ] 

	 
	
	 600 Montgomery Street
	 
	 ,  Suite 1700
	
	  ,  San Francisco, 
	   CA, 
	  
	
	  
		
		, 
		
	    
	    
		    
			  
			
			 
		
		
		
		 USA
		
	
	    
	    

		
	


		  Industry
		

		 Biotechnology 
		

			Offering Data
		

			Revenue range: Decline to Disclose


Date of first sale: 
2016-09-22


			
				[ Equity ]
			
		

			Total offer 
		
 
			$ 22,000,000
		

			Total sold 
		
 
			$ 12,000,000
		

			Total remaining 
		
 
			$ 10,000,000
		

			# investors
		
 
			3 investors have already invested in this offering
		



			Signature
		


				Genten Therapeutics, Inc. [ Edward Y. Kim ]  
				Edward Y. Kim [ Assistant Secretary ] 2016-10-03
			
















Type
Filing
Company
SIC
Rel
IRS #
State of INC
FY End
Mailing address
Former
Filing Vals


filer







Genten Therapeutics, Inc.
 Cik: 0001685989
		  
		
			


	
		

	 
	
	 600 MONTGOMERY STREET
	 
	
	
	   SAN FRANCISCO, 
	   CA, 
	   94111
	
	  
		
		

			
			 
		
		
		
		 USA
		
	
	    
	    

		
		

 


813858436



			USA 
		
		[ DE ] 
1231



	 
	
	 600 MONTGOMERY STREET
	 
	
	
	   SAN FRANCISCO, 
	   CA, 
	   94111
	
	  
		
		

			
			 
		
		
		
		 USA
		
	
	    
	    

			
		
	




form typeD
act33
file number021-271704
film number161915358
























































	Genten Therapeutics Inc. - Company Profile - BioCentury




























































Publications
archives
BCIQ
Conferences
version 4.3.15.600





Free Trial / Subscribe


SIGN IN



English
简体中文
日本語
한국어







Biocentury





Menu





                                        Home
                                        
+




                                        Publications
                                        
+



Publications Home >


BioCentury>


BC Innovations>


BC Extra>


BC Week In Review>


Current Issues>




Archives 
                                        
+



Archives Home >


Basic Search>


Advanced Search>


Back Issues>




BCIQ
                                        
+



BCIQ Home >


Overview>


Pipeline Analyst>


Financial Analyst>


Company Analyst>


Deal Analyst>




Conferences 
                                        
+




Conferences Home >


Newsmakers


Bio€quity Europe


Future Leaders


China Healthcare Summit


Other Industry Events





eLearning 
                                        
+



eLearning Home >


Videos>


White Papers>


                                            Follow Us
                                            


























BCIQ / Company Profile


BCIQ Overview   |    
                        Settings   |   
                        Support















Biocentury



Print this                                                    
                        
















                         
                            

    

    

    
                         
                        



                            Genten Therapeutics Inc.
                        









print preview


export


bookmark


share with colleague





















General Information
                    






 Location

Germantown, Md.


 Region

Mid-Atlantic


 Country

U.S.


 Business Category

Autoimmune


 Year Founded

2016


 Website





 Lead Product Status

Discovery






















 Archive Items are loading
                            













 Financial Information
                        






 Financing
                                                Summary







 Financing Details







 Earnings
                                    Summary
                                






 Stocks Annual Chart
                                





















 Pipeline Information
                        






 Pipeline
                                                Summary







 Pipeline Details




















 Deals Information
                        






 Deals
                                                Summary







 Deals Details






















About Biocentury


Company Overview


Management


Editorial & Research




Contact


Contact Us


Advertising & Sponsorship


Career Opportunities




Support


Forgot Password


Customer Service


Reprints


FAQs




Products & Solutions


Products Overview


Publications


Archives


BCIQ


Conferences


eLearning


RSS Feeds




Legal


User Agreement


Terms of Use


Privacy Policy


Your California Privacy Rights


Use of Images

Follow Us
                            











What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.

Sign in
Free Trial












© 2017 BioCentury Inc. All Rights Reserved.
     
                        Terms & Conditions
                          |  
                        Privacy Policy











Set Email Alert






dummy











